Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus
Open Access
Abstract
Antimicrobial peptides (AMP) are essential components of innate immunity with a broad range of antimicrobial activities against bacteria, viruses, and fungi. The aim of this study was to investigate AMP expression in the upper gastrointestinal tract in normal and pathological metabolic states in humans. Furthermore, we examined the correlation between vitamin D levels and AMP expression in the same cohort. Serum concentrations of 25-hydroxyvitamin D3 were measured, and mRNA expression of β-defensins HBD-1, -2, -3, -4, α-defensins HD-5 and -6 and cathelicidin in the upper gastrointestinal tract epithelia were determined by quantitative RT-PCR in 31 individuals (10 with type 2 diabetes, 10 with insulin resistance, and 11 healthy controls). The majority of the cohort showed low vitamin D concentrations, which were negatively correlated with mRNA expression levels of HBD-3 in corpus mucosa. HBD-1 and HBD-3 mRNA were expressed in corpus mucosa, with the former significantly decreased in patients with diabetes. Hence, we conclude that type 2 diabetes is associated with reduced AMP expression in the upper gastrointestinal tract, which might contribute towards epithelial barrier dysfunction and increased bacterial translocation in these patients.Keywords
This publication has 49 references indexed in Scilit:
- Association of Diabetes and HbA1c Levels With Gastrointestinal ManifestationsDiabetes Care, 2012
- Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2011
- Molecular mechanisms of metabolic regulation by insulin in DrosophilaBiochemical Journal, 2009
- Antimicrobial host defense in the upper gastrointestinal tractEuropean Journal of Gastroenterology & Hepatology, 2008
- Glucose regulation of β-defensin-1 mRNA in human renal cellsBiochemical and Biophysical Research Communications, 2007
- Innate immune defence in the human gastrointestinal tractMolecular Immunology, 2005
- Oesophageal defensin expression during Candida infection and reflux diseaseScandinavian Journal of Gastroenterology, 2005
- Expression and regulation of antimicrobial peptides in the gastrointestinal tractJournal of Leukocyte Biology, 2003
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cellsFEBS Letters, 1996